In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

International Journal of Antimicrobial Agents

Volumn 22, Issue SUPPL. 2, 2003, Pages 53-59

  Marchese, Anna ^a   Gualco, Laura ^a   Debbia, Eugenio A ^a   Schito, Gian Carlo ^a   Schito, Anna Maria ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Fosfomycin; In vitro activity; Uropathogens; Virulence factors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COLICIN; COTRIMOXAZOLE; FOSFOMYCIN; NITROFURANTOIN; NORFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CITROBACTER FREUNDII; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG POTENCY; ENTEROBACTER CLOACAE; EPITHELIUM CELL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GROWTH RATE; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEUS MIRABILIS; SERRATIA MARCESCENS; ULTRAVIOLET IRRADIATION; URINARY TRACT INFECTION; URINE CATHETER;

EID: 0141646506     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00230-9     Document Type: Article

References (25)

1. Reeves D.S. Fosfomycin trometamol. J. Antimicrob. Chemother. 34:1994;853-858.
2. Naber K.G. Treatment options for acute uncomplicated cystitis in adults. J. Antimicrob. Chemother. 46:(Suppl. S1):2000;23-27.
3. Piddock L.J.V. Fluoroquinolone resistance. Br. Med. J. 317:1998;1029-1030.
4. Garau J., Xercavis M., Rodriguez-Carballeira M., et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob. Agents Chemother. 43:1999;2736-2741.
5. Kahlmeter G. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J. Antimicrob. Chemother. 46:(Suppl. S1):2000;15-22.
6. Woodruff H.B., Mata J.M., Hernandez S., et al. Fosfomycin: laboratory studies. Chemotherapy. 23:(Suppl. 1):1977;1-22.
7. Martinez J.L., Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44:2000;1771-1777.
8. Azoulay-Dupuis E., Rieux V., Muffat-Joly M., et al. Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob. Agents Chemother. 44:2000;1575-1577.
9. Li Pira G., Pruzzo C., Schito G.C. Monuril and modification of pathogenicity traits in resistant microorganisms. Eur. Urol. 13:(Suppl. 1):1987;92-97.
10. Gunn J.S. Mechanism of bacterial resistance and response to bile. Microb. Infect. 2:2000;907-913.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.: Approved Standard M7-A5 (2002) and M100-S12 (2002). Wayne, PA: NCCLS.
12. Ofek I., Mirelman D., Sharon N., Wayne P.A. Adherence of E. coli to human mucosal cells mediate by mannose receptors. Nature. 265:1977;623-625.
13. Miller J.H. Experiments in molecular genetics. 1977;Cold Spring Harbor, New York.
14. Debbia E., Pruzzo C. Positive selection of colicin cured cells by mitomycin in Klebsiella pneumoniae. Microbiologica. 7:1984;193-196.
15. Debbia E.A., Massaro S., Campora U., Schito G.C. Inhibition of F'lac transfer by various antibacterial drugs in Escherichia coli. Microbiologica. 17:1994;65-68.
16. Arzouni J.P., Bouilloux J.P., de Mouy D., et al. Urinary tract infections in women aged 15 to 65 years in open care practice: monitoring of Escherichia coli sensitivity to fosfomycin trometamol on the basis of the previous history. Med. Malad. Infect. 30:2000;699-702.
17. Chomarat M. Resistance of bacteria in urinary tract infections. Int. J. Antimicrob. Agents. 16:2000;483-487.
18. Cozzarelli N.R., Koch J.P., Hayashi S., Lin E.C.C. Growth stasis by accumulated L-α-glycerophosphate in E. coli. J. Bacteriol. 90:1965;1325-1329.
19. Walker G.C., Smith B.T., Sutton M.D. The SOS response to DNA damage. Storz G., Hengge-Aronis R. Bacterial stress response. 2000;American Society for Microbiology, Washington, DC.
20. Nicolle L.E. A practical guide to the management of complicated urinary tract infection. Drugs. 53:1997;583-592.
21. O'Brien G.J., Chambers S.T., Peddie B., Mahanty H.K. The association between colicinogenicity and pathogenesis among uropathogenic isolates of Escherichia coli. Microb. Pathog. 20:(Suppl. 3):1996;185-190.
22. Tan Y., Riley M.A. Rapid invasion by colicinogenic Escherichia coli with novel immunity functions. Microbiology. 142:1996;2175-2180.
23. Bergstrom C.T., Lipsitch M., Levin B.R. Natural selection, infectious transfer and existence conditions for bacterial plasmids. Genetics. 155:2000;1505-1519.
24. Arca P., Reguera G., Hardisson C. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J. Antimicrob. Chemother. 40:1997;393-399.
25. Suarez J.E., Mendoza M.C. Plasmid-encoded fosfomycin resistance. Antimicrob. Agents Chemother. 35:1991;791-795.